In addition, the emergence of cancer-specific Le antigens is clinically used as a cancer biomarker, such as sialyl Lea (CA19-9) [22], demonstrating the physiological and pathological significance of Le type Fuc residues. The gene discussed is FUT3; the disease is cancer.